These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37196626)

  • 1. Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcome.
    Contreras Yametti GP; Evensen NA; Schloss JM; Aldebert C; Duan E; Zhang Y; Hu J; Chambers TM; Scheurer ME; Teachey DT; Rabin KR; Raetz EA; Aifantis I; Carroll WL; Witkowski MT
    Blood Adv; 2023 Aug; 7(15):3928-3931. PubMed ID: 37196626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma.
    DiGiuseppe JA; Wood BL
    Cytometry B Clin Cytom; 2019 Jul; 96(4):256-265. PubMed ID: 31231940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytopenia as a diagnostic clue to pediatric B-lymphoblastic leukemia with rare circulating blasts.
    Park SI; Rogers BB
    Pediatr Dev Pathol; 2014; 17(2):112-7. PubMed ID: 24804826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric standardization of minimal/measurable residual disease in B-cell precursor acute lymphoblastic leukaemia using next-generation flow cytometry in a low/middle-level income country.
    Ikoma-Colturato MRV; Bertolucci CM; Conti-Spilari JE; Oliveira E; Simioni AJ; Figueredo-Pontes LL; Furtado FM; Alegretti AP; Azambuja AP; Gevert F; Gomes BE; Avelar DMV; Soares ACCV; Ramos PM; Santos B; Cortez ML; Beltrame MP; Bacal NS; Wagner A; Lucena-Silva N; Sandes AF; Cunha F; Oliveira GHM; Costa ES; Yamamoto M
    Br J Haematol; 2023 Feb; 200(3):381-384. PubMed ID: 36222259
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
    Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
    Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B Lymphoblastic Leukemia Minimal Residual Disease Assessment by Flow Cytometric Analysis.
    Shaver AC; Seegmiller AC
    Clin Lab Med; 2017 Dec; 37(4):771-785. PubMed ID: 29128068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is B-lineage acute lymphoblastic leukemia with a mature phenotype and l1 morphology a precursor B-lymphoblastic leukemia/lymphoma or Burkitt leukemia/lymphoma?
    Li S; Lew G
    Arch Pathol Lab Med; 2003 Oct; 127(10):1340-4. PubMed ID: 14521459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PAX5 P80R pediatric B acute lymphoblastic leukemia with monocytic lineage switch at diagnosis: Deciphering classification ambiguity.
    Strullu M; Caye-Eude A; Fenneteau O; Arfeuille C; Cuccuini W; Cavé H; Baruchel A; Lainey E
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30842. PubMed ID: 38189777
    [No Abstract]   [Full Text] [Related]  

  • 9. Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
    Verbeek MWC; Buracchi C; Laqua A; Nierkens S; Sedek L; Flores-Montero J; Hofmans M; Sobral de Costa E; Nováková M; Mejstrikova E; Barrena S; Kohlscheen S; Szczepanowski M; Kulis J; Oliveira E; Jugooa R; de Jong AX; Szczepanski T; Philippé J; van Dongen JJM; Orfao A; Brüggemann M; Gaipa G; van der Velden VHJ
    Br J Haematol; 2022 Apr; 197(1):76-81. PubMed ID: 34881427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia: verification of leukemic state by flow-sorting and molecular/cytogenetic methods.
    Øbro NF; Ryder LP; Madsen HO; Andersen MK; Lausen B; Hasle H; Schmiegelow K; Marquart HV
    Haematologica; 2012 Jan; 97(1):137-41. PubMed ID: 21933850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia.
    Demina I; Voropayev A; Semchenkova A; Zerkalenkova E; Olshanskaya Y; Samochatova E; Novichkova G; Miakova N; Maschan A; Popov A
    Leuk Res; 2021 Jan; 100():106491. PubMed ID: 33340851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric immunophenotyping of cerebrospinal fluid specimens.
    Craig FE; Ohori NP; Gorrill TS; Swerdlow SH
    Am J Clin Pathol; 2011 Jan; 135(1):22-34. PubMed ID: 21173121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification.
    De Zen L; Orfao A; Cazzaniga G; Masiero L; Cocito MG; Spinelli M; Rivolta A; Biondi A; Zanesco L; Basso G
    Leukemia; 2000 Jul; 14(7):1225-31. PubMed ID: 10914546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneuploidy in childhood B cell acute lymphoblastic leukaemia - also a relevant prognostic factor in relapsed disease?
    Zugmaier G
    Br J Haematol; 2019 Mar; 184(6):895-896. PubMed ID: 30723892
    [No Abstract]   [Full Text] [Related]  

  • 16. The prognostic significance of hematogones in childhood B-cell acute lymphoblastic leukemia.
    Arabi S; Yousefian S; Kavosh A; Mansourian M; Nematollahi P
    Pediatr Blood Cancer; 2023 Feb; 70(2):e30138. PubMed ID: 36495254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized leukemia cutis as the initial manifestation of precursor B-cell acute lymphoblastic leukemia in a young male.
    Kanoje PK; Khullar G; Yadav AK; Saxena AK; Gupta DK
    Dermatol Ther; 2021 Jan; 34(1):e14594. PubMed ID: 33247514
    [No Abstract]   [Full Text] [Related]  

  • 18. High frequency of heat shock protein 27 overexpression is a highly effective, high-coverage marker for minimal residual disease detection in children with B-cell acute lymphoblastic leukemia.
    Chou SW; Su YH; Lu MY; Chang HH; Yang YL; Lin DT; Lin KH; Coustan-Smith E; Jou ST
    Pediatr Blood Cancer; 2023 Jan; 70(1):e29990. PubMed ID: 36250996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification.
    De Zen L; Bicciato S; te Kronnie G; Basso G
    Leukemia; 2003 Aug; 17(8):1557-65. PubMed ID: 12886243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.